Jun 03, 2020
Haemonetics Announces Blood Filter Supply Agreement And Sale Of Puerto Rico-Based Manufacturing Operations To GVS, S.p.A
May 28, 2020
Haemonetics Announces Sale Of U.S. Blood Donor Management Software Solution Assets To The GPI Group
Apr 17, 2020
Michael Coyle Joins Haemonetics Board of Directors
Apr 02, 2020
Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
Feb 04, 2020
Haemonetics 3rd Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website
Jan 14, 2020
Haemonetics Announces Acquisition Of Intellectual Property Assets Relating To TEG® 6s Hemostasis Analyzer System
Dec 19, 2019
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2020 Results: February 4, 2020
Dec 11, 2019
Haemonetics Opens New Corporate Headquarters In Downtown Boston
Dec 03, 2019
Haemonetics Releases Next Generation SafeTrace Tx® Transfusion Management Software in North America
Nov 01, 2019
Haemonetics 2nd Quarter and First Half Fiscal 2020 Earnings Release Available on Investor Relations Website
Sep 17, 2019
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2020 Results: November 1, 2019
Sep 12, 2019
Haemonetics Appoints Stewart W. Strong As President, Global Hospital
Aug 28, 2019
Haemonetics to Present at the 17th Morgan Stanley's Annual Global Healthcare Conference
May 14, 2019
Haemonetics To Transfer Union, South Carolina, Manufacturing Facility To CSL Plasma Inc.
Mar 25, 2019
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2019 Results: May 7, 2019
Dec 20, 2018
Haemonetics Sets Date for Publishing Third Quarter Fiscal 2019 Results: February 5, 2019
Dec 19, 2018
Haemonetics Announces Headquarters Relocation To Boston
Aug 30, 2018
Haemonetics to Present at Morgan Stanley's Global Healthcare Conference
Aug 07, 2018
Haemonetics Appoints Josep Lluis Llorens As Senior Vice President, Global Manufacturing And Supply Chain
Jul 19, 2018
Haemonetics Sets Date for Publishing First Quarter Fiscal 2019 Results: August 7, 2018